Natixis Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Natixis Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,189	Closed	-$640K	–	1266
2020 Q3	$640K	Buy	12,189 +209	+2%	+$8.65K	﹤0.01%	1012
2020 Q2	$399K	Buy	+11,980	New	+$381K	﹤0.01%	1093

Natixis Advisors's MNTA Position: Q4 2020 in Review

Natixis Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 12,189 shares — an estimated $640K sold.

Natixis Advisors first reported a position in MNTA in Q2 2020 and held it in 2 quarters. The position peaked at $640K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Natixis Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Natixis Advisors sold 12,189 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $640K.
Natixis Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 2 quarters.
Natixis Advisors's Momenta Pharmaceuticals, Inc. position peaked at $640K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Natixis Advisors's 13F filing for Q4 2020, filed 12 Feb 2021.